Together we will beat cancer

Donate

Opinion: What should the cancer agenda look like for the new Prime Minister?

The last couple of weeks has been quite the firestorm for the new Truss administration. When the Prime Minister and…

Read More

Steps towards a smokefree society

For some, a world where cigarettes don’t exist might be difficult to imagine. Less than 30 years ago it would’ve…

Read More

Making real change: 4 ways we’ve influenced cancer policy

From restricting sunbed use for under 18s, to banning smoking at work and in public places, here are 4 ways we’ve influenced cancer policy and made real change.

Read More

‘Levelling Up’: What should it mean for cancer?

The UK Government has set out how they’ll help parts of the country to catch up on a range of measures, including health.

Read More

Ovarian, bowel and non-Hodgkin’s lymphoma treatments approved for NHS use in Scotland

Three new treatment options made available for cancer patients in Scotland.

Read More

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

Read More

First targeted treatment approved for advanced prostate cancer on NHS in Scotland

The targeted drug olaparib has been approved for some people with a type of advanced prostate cancer on the NHS in Scotland.

Read More

Cancer Won’t Wait: “I prayed she would see her daughter start school”

We spoke to 4 people about why, when it comes to cancer, every second counts and why the Government must act now to ensure the NHS can catch more cancers early.

Read More

Cancer target missed for 55,000 patients over 6 years

In the last 6 years, almost 55,000 cancer patients should have been diagnosed or started their treatment sooner, according to new calculations.

Read More

NHS lung cancer patients in England get early access to ‘breakthrough’ cancer drug

The Medicines and Healthcare products Regulatory Agency has approved the first-of-its-kind drug sotorasib for some people with non small cell lung cancer.

Read More